Literature DB >> 17137767

[Etidronate per os in subcutaneous fat necrosis with hypercalcemia and nephrocalcinosis].

B Trullemans1, J Bottu, J-P Van Nieuwenhuyse.   

Abstract

Subcutaneus fat necrosis is an uncommon disease which may be complicated with potentially fatal hypercalcemia. The usual treatment of hypercalcemia includes hyperhydratation, corticosteroids and diet. This treatment is not always effective in normalizing plasma calcium concentration. A treatment with bisphosphonates has been effective in similar cases. We report on the case of a patient presenting with symptomatic hypercalcemia, complicated with nephrocalcinosis consecutive to subcutaneus fat necrosis after birth asphyxia at term. Oral etidronate has been used for 3 weeks, after failure of classical treatment. The evolution was favorable. After a short review of the complications of subcutaneus fat necrosis, we discuss the use of bisphophonates in this indication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17137767     DOI: 10.1016/j.arcped.2006.10.015

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  3 in total

1.  Severe neonatal hypercalcemia caused by subcutaneous fat necrosis without any apparent cutaneous lesion.

Authors:  Laurent Bonnemains; Stephanie Rouleau; Gaelle Sing; Claude Bouderlique; Regis Coutant
Journal:  Eur J Pediatr       Date:  2008-03-26       Impact factor: 3.183

2.  Treatment with bisphosphonates in severe hypercalcemia due to subcutaneous fat necrosis in an infant with hypoxic-ischemic encephalopathy.

Authors:  E Pérez Martínez; M Camprubí Camprubí; M Ramos Cebrián; J Antón López; A Apodaca Saracho; M G Lopez Ramos; A García-Alix
Journal:  J Perinatol       Date:  2014-06       Impact factor: 2.521

3.  Subcutaneous Fat Necrosis and Hypercalcemia with Nephrocalcinosis in Infancy: Case Report and Review of the Literature.

Authors:  Katerina Chrysaidou; Georgios Sargiotis; Vasiliki Karava; Dimitrios Liasis; Victor Gourvas; Vissarios Moutsanas; Athanasios Christoforidis; Stella Stabouli
Journal:  Children (Basel)       Date:  2021-05-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.